Evidence That Endogenous Calcitonin Protects Against Renal Bone Disease
Overview
Authors
Affiliations
Plasma concentrations of calcium, phosphate, alkaline phosphatase (A.P.), immunoreactive calcitonin (iC.T.), and immunoreactive parathyroid hormone (iP.T.H.) were measured in fifty-two patients with chronic renal failure on maintenance haemodialysis. On the basis of a bimodal distribution of values for plasma-A.P. the patients were dividied into 2 groups. In those patients with normal A.P. concentratons as well as in twenty-eight normal subjects there was a positive correlation between iP.T.H. and iC.T. which was independent of plasma calcium or phosphate. Patients with increased plasma-A.P. had higher concentrations of iP.T.H., lower concentrations of iC.T., and showed a negative relation between the concentrations of the two hormones. It is suggested that a possible factor in the pathogenesis of renal bone disease is a failure to secrete C.T. in adequate amounts.
On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism.
Kruse K Eur J Pediatr. 1982; 138(3):202-5.
PMID: 7117282 DOI: 10.1007/BF00441202.
Lunetta M, Infantone E, Spanti D, MUGHINI L J Endocrinol Invest. 1981; 4(2):185-8.
PMID: 7024392 DOI: 10.1007/BF03350449.
Hormonal derangements in uremia.
Tolis G, Goltzman D, Guyda H, Mountokalakis T J Endocrinol Invest. 1980; 3(1):83-97.
PMID: 6989891 DOI: 10.1007/BF03348224.
Plasma calcitonin in rats with renal failure.
Onishi T, Deftos L Calcif Tissue Int. 1988; 42(3):181-4.
PMID: 3130166 DOI: 10.1007/BF02556331.
Nishiyama S, Kuwahara T, Matsuda I Eur J Pediatr. 1986; 144(5):457-63.
PMID: 3007152 DOI: 10.1007/BF00441738.